Skip to content

China Venous Thrombosis Trial

China Venous Thrombosis Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-15007355
Enrollment
Unknown
Registered
2015-11-07
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous thrombosis

Interventions

NA:NA

Sponsors

Institute of Hematology, Union Hospital, Tongji Medical Colledge, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: All research centers will include the consecutive unrelated Chinese patients who were diagnosed with VTE (deep vein thrombosis and/or pulmonary embolism), no matter whether first episode or recurrent thrombosis, no matter whether following malignant tumor or other acquired risk factors. The thrombosis should be in line with: and . Briefly, the diagnosis will be based on clinical manifestations, D-dimer levels, Doppler ultrasound (for deep vein thrombosis), ventilation perfusion lung scan, and/or computed tomography angiography (for pulmonary embolism). Age- and sex-matched healthy controls without an individual or family history of VTE should be enrolled from each center in the same region during the same time window. The total number of participants in control group should be 1.2-fold of that of the case group.

Exclusion criteria

Exclusion criteria: Patients who were younger than 18 years and refused to participate in this investigation will be excluded. The kinship between patients should be recorded.

Design outcomes

Primary

MeasureTime frame
venous thromboembolism;

Countries

China

Contacts

Public ContactYu Hu
dr_huyu@126.com+86 13986183871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026